Cellosaurus cell line B901L (CVCL_U098)

• Mutation; HGNC; 3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Unspecified (PubMed=21498706).
  

PubMed=11267941; DOI=10.1111/j.1349-7006.2001.tb01096.x
Takenoyama M., Yoshino I., Eifuku R., So T., Imahayashi S., Sugaya M., Yasuda M., Inoue M., Ichiyoshi Y., Osaki T., Nagashima A., Nomoto K., Yasumoto K.
Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells.
Jpn. J. Cancer Res. 92:309-315(2001)

PubMed=12114371; DOI=10.1378/chest.122.1.282
Sugaya M., Takenoyama M., Osaki T., Yasuda M., Nagashima A., Sugio K., Yasumoto K.
Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapy.
Chest 122:282-288(2002)

PubMed=16651449; DOI=10.1158/0008-5472.CAN-05-3840
Fukuyama T., Hanagiri T., Takenoyama M., Ichiki Y., Mizukami M., So T., Sugaya M., So T., Sugio K., Yasumoto K.
Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.
Cancer Res. 66:4922-4928(2006)

PubMed=17511773; DOI=10.1111/j.1349-7006.2007.00507.x
Fukuyama T., Ichiki Y., Yamada S., Shigematsu Y., Baba T., Nagata Y., Mizukami M., Sugaya M., Takenoyama M., Hanagiri T., Sugio K., Yasumoto K.
Cytokine production of lung cancer cell lines: correlation between their production and the inflammatory/immunological responses both in vivo and in vitro.
Cancer Sci. 98:1048-1054(2007)

PubMed=17725806; DOI=10.1111/j.1349-7006.2007.00586.x
Baba T., Hanagiri T., Ichiki Y., Kuroda K., Shigematsu Y., Mizukami M., Sugaya M., Takenoyama M., Sugio K., Yasumoto K.
Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
Cancer Sci. 98:1795-1802(2007)

PubMed=21498706
Onitsuka T., Uramoto H., Tanaka F.
Lack of direct association between EGFR mutations and ER beta expression in lung cancer.
Anticancer Res. 31:855-860(2011)